As the Director of Business Development - Corporate Strategy at Alcon, Yi Sun plays a pivotal role in shaping the future of ophthalmology and eye care through strategic partnerships and innovative initiatives. With over a decade of experience in strategy, consulting, and corporate development, Yi...
As the Director of Business Development - Corporate Strategy at Alcon, Yi Sun plays a pivotal role in shaping the future of ophthalmology and eye care through strategic partnerships and innovative initiatives. With over a decade of experience in strategy, consulting, and corporate development, Yi leverages a robust expertise in external innovation, mergers and acquisitions, and licensing to drive growth in the med tech sector. His current focus includes identifying and collaborating with start-ups, academic institutions, and industry leaders to foster groundbreaking advancements in eye care technologies.
Yi's strategic vision is complemented by his proficiency in business strategy, competitive analysis, and due diligence, enabling him to navigate the complexities of the healthcare landscape effectively. He is particularly passionate about the digital transformation of healthcare, recognizing the potential of technology to enhance patient outcomes and streamline operations within the ophthalmology field. His work involves not only assessing market trends but also engaging in financial modeling and business analysis to ensure that Alcon remains at the forefront of innovation.
Key projects under Yi’s leadership include the development of strategic alliances that enhance Alcon’s product offerings and expand its market reach. By fostering a culture of collaboration and change management, he empowers teams to embrace new ideas and adapt to the rapidly evolving healthcare environment. Yi Sun’s commitment to excellence and his strategic acumen make him a vital asset to Alcon, driving the company’s mission to improve vision and enhance quality of life for patients worldwide.
